Certified by Founder Lodge
Casdin Capital, LLC
United States - New York, New York
INVESTOR
1 Disclosed Funding Rounds $200,000,000
16 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Casdin Capital, LLC is a New York-based research investment firm focused on the innovations in molecular medicine currently reshaping Life Sciences and healthcare. Founded in 2011, and with a
| Company | Date | Round | Raised |
|---|---|---|---|
 Octave (US) |
July, 27 ,2023 | Series B | $30,000,000 |
 Asimov |
January, 09 ,2023 | Series B | $200,000,000 |
 IDRx |
August, 02 ,2022 | Series A | $122,000,000 |
 Remix Therapeutics |
January, 04 ,2024 | Unknown | $60,000,000 |
 Arzeda |
April, 04 ,2022 | Series B | $33,000,000 |
 Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
 Flare Therapeutics |
March, 23 ,2023 | Series B | $123,000,000 |
 TMRW Life Sciences |
July, 25 ,2024 | Series D | $28,000,000 |
 Function Oncology |
April, 13 ,2023 | Series A | $28,000,000 |
 Orbital Therapeutics |
April, 27 ,2023 | Series A | $270,000,000 |
 Septerna |
July, 18 ,2023 | Series B | $150,000,000 |
| Octave (US) |
July, 27 ,2023 | Series B | $30,000,000 |
| Remix Therapeutics |
January, 04 ,2024 | Unknown | $60,000,000 |
| Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
| TMRW Life Sciences |
July, 25 ,2024 | Series D | $28,000,000 |
 Maze Therapeutics |
December, 04 ,2024 | Series D | $115,000,000 |
Founderpath
Truework
Finix
Farther
TeamApt Inc.
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
